Production of human B cell hybridomas with interleukin 2 receptors selected by a new selective medium, HAT-neo.
Ikewaki
N
N
D000954:Antigens, Surface / Q000032:analysis; D001402:B-Lymphocytes / Q000378:metabolism* / Q000502:physiology; D002460:Cell Line; D004351:Drug Resistance / Q000235:genetics; D006801:Humans; D006825:Hybridomas / Q000276:immunology / Q000378:metabolism*; D008223:Lymphoma / Q000276:immunology / Q000378:metabolism; D015375:Receptors, Interleukin-2 / Q000096:biosynthesis*; D014162:Transfection
D000954:Antigens, Surface; D015375:Receptors, Interleukin-2